NI201200049A - Proceso para la preparación de compuestos de 2 - ( 1 - feniletil ) isoindolina - 1 - uno - Google Patents

Proceso para la preparación de compuestos de 2 - ( 1 - feniletil ) isoindolina - 1 - uno

Info

Publication number
NI201200049A
NI201200049A NI201200049A NI201200049A NI201200049A NI 201200049 A NI201200049 A NI 201200049A NI 201200049 A NI201200049 A NI 201200049A NI 201200049 A NI201200049 A NI 201200049A NI 201200049 A NI201200049 A NI 201200049A
Authority
NI
Nicaragua
Prior art keywords
isoindoline
compounds
preparation
phenylethyl
methods
Prior art date
Application number
NI201200049A
Other languages
English (en)
Inventor
J Frank Anthony
Ge Chuangseng
Saindaine Manohar
- Wah Man Hon
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of NI201200049A publication Critical patent/NI201200049A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Se describen métodos para la preparación de compuestos de isoindolina - 1 - uno.
NI201200049A 2009-10-09 2012-03-30 Proceso para la preparación de compuestos de 2 - ( 1 - feniletil ) isoindolina - 1 - uno NI201200049A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25042109P 2009-10-09 2009-10-09

Publications (1)

Publication Number Publication Date
NI201200049A true NI201200049A (es) 2012-11-27

Family

ID=43301314

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201200049A NI201200049A (es) 2009-10-09 2012-03-30 Proceso para la preparación de compuestos de 2 - ( 1 - feniletil ) isoindolina - 1 - uno

Country Status (21)

Country Link
US (1) US8415485B2 (es)
EP (1) EP2486012B1 (es)
JP (1) JP5753177B2 (es)
KR (1) KR20120084306A (es)
CN (1) CN102639498A (es)
AR (1) AR078581A1 (es)
AU (1) AU2010303243B2 (es)
BR (1) BR112012007737A2 (es)
CA (1) CA2775581A1 (es)
CR (1) CR20120169A (es)
EC (1) ECSP12011781A (es)
ES (1) ES2451350T3 (es)
HK (1) HK1168596A1 (es)
IL (1) IL218898A0 (es)
MX (1) MX2012004024A (es)
MY (1) MY183201A (es)
NI (1) NI201200049A (es)
NZ (1) NZ599147A (es)
RU (1) RU2557236C2 (es)
WO (1) WO2011044479A1 (es)
ZA (1) ZA201202380B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR090100A1 (es) 2012-02-21 2014-10-22 Celgene Corp Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
EP3539539A1 (en) 2013-06-17 2019-09-18 Celgene Corporation Tablet formulations of (+)-2-[1 -(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione
CN104447443B (zh) * 2014-12-05 2016-07-27 新发药业有限公司 一种阿普斯特及其中间体的制备方法
CN115850129B (zh) * 2023-02-28 2023-05-16 凯莱英生命科学技术(天津)有限公司 （s）-1-(3-乙氧基-4-甲氧基苯基)-2-（甲磺酰基）乙胺的制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL88035A0 (en) * 1987-10-27 1989-06-30 American Home Prod Benzopyran derivatives,their preparation and pharmaceutical compositions containing them
US5703098A (en) * 1994-12-30 1997-12-30 Celgene Corporation Immunotherapeutic imides/amides
US6020358A (en) 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels
US6667316B1 (en) * 1999-11-12 2003-12-23 Celgene Corporation Pharmaceutically active isoindoline derivatives
US20100129363A1 (en) * 2002-05-17 2010-05-27 Zeldis Jerome B Methods and compositions using pde4 inhibitors for the treatment and management of cancers
ATE449081T1 (de) * 2002-12-30 2009-12-15 Celgene Corp Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
KR20050111759A (ko) * 2003-03-12 2005-11-28 셀진 코포레이션 7-아미노-이소인돌릴 화합물 및 그의 제약학적 용도
CH696542A5 (de) * 2003-07-09 2007-07-31 Siegfried Ltd Verfahren zur Herstellung von substituierten 2,6-Dioxopiperidin-3-yl-Verbindungen.
WO2005054176A1 (en) * 2003-11-25 2005-06-16 Eli Lilly And Company Peroxisome proliferator activated receptor modulators
US7244759B2 (en) * 2004-07-28 2007-07-17 Celgene Corporation Isoindoline compounds and methods of making and using the same
TW200613272A (en) * 2004-08-13 2006-05-01 Astrazeneca Ab Isoindolone compounds and their use as metabotropic glutamate receptor potentiators
US7142423B2 (en) * 2004-10-26 2006-11-28 Comarco Wireless Technologies, Inc. Power adapter with fan assembly
CN101277934A (zh) * 2005-08-12 2008-10-01 阿斯利康(瑞典)有限公司 使代谢型谷氨酸-受体-增效的异吲哚酮
TW200804281A (en) * 2006-02-16 2008-01-16 Astrazeneca Ab New metabotropic glutamate receptor-potentiating isoindolones
US20100267712A1 (en) * 2007-09-27 2010-10-21 The United States of America, as represented by the Secretary, Department of Health and Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
CA2718412A1 (en) * 2008-03-24 2009-10-01 Celgene Corporation Treatment of psoriasis or psoriatic arthritis using cyclopropyl-n-{2-{(1s)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide

Also Published As

Publication number Publication date
IL218898A0 (en) 2012-06-28
MY183201A (en) 2021-02-18
WO2011044479A1 (en) 2011-04-14
ZA201202380B (en) 2013-06-26
NZ599147A (en) 2014-03-28
KR20120084306A (ko) 2012-07-27
JP5753177B2 (ja) 2015-07-22
MX2012004024A (es) 2012-05-08
EP2486012A1 (en) 2012-08-15
AU2010303243B2 (en) 2014-08-28
AU2010303243A1 (en) 2012-05-03
US8415485B2 (en) 2013-04-09
CN102639498A (zh) 2012-08-15
AR078581A1 (es) 2011-11-16
ES2451350T3 (es) 2014-03-26
HK1168596A1 (en) 2013-01-04
ECSP12011781A (es) 2012-07-31
US20110087033A1 (en) 2011-04-14
BR112012007737A2 (pt) 2015-09-15
RU2012118615A (ru) 2013-11-20
RU2557236C2 (ru) 2015-07-20
CA2775581A1 (en) 2011-04-14
EP2486012B1 (en) 2013-12-11
CR20120169A (es) 2012-07-30
JP2013507389A (ja) 2013-03-04

Similar Documents

Publication Publication Date Title
UY34352A (es) 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante
UY34467A (es) Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
UY34472A (es) Derivados modificados de 4-fenil-piridina
CR20140534A (es) Proceso para la preparación de treprostinil y derivado de los mismos
CL2008001897A1 (es) Proceso para la preparacion de 3-halometil-1-metil-1h-pirazol, utiles como intermediario en la produccion de fungicidas; compuestos derivados de 3-halometil-1-metil-1h-pirazol.
UY34824A (es) Nucleósidos de espirooxetano de uracilo
CL2011002943A1 (es) Anticuerpo triespecifico o tetraespecifico; metodo para la preparacion de dicho anticuerpo; celula huesped; composicion farmaceutica.
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
UY34097A (es) Alineación de anticoagulante de cebado para extracción de sangre.
CL2012002082A1 (es) Proceso para la preparacion de lacosamida, por hidroximetilación; compuestos intermediarios.
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
CL2012000278A1 (es) Proceso para la obtencion de derivados de 5-trifluorometil-pirimidinas; y uno de los compuestos intermediarios considerados.
AU2014230812A8 (en) Process for making benzoxazepin compounds
CL2012003491A1 (es) Compuesto derivado de dihidropirrol sustituidos; proceso para preparar dichos derivados en forma estereoselectiva.
BR112013016241A2 (pt) composto, e, método para fabricar um composto
UY34329A (es) Compuestos de triazolopiridina
AR058253A1 (es) Procedimiento para la preparacion de ferri-succinilcaseina
UY33976A (es) Derivados de pirazolo-pirimidina.
CL2014002318A1 (es) Procedimiento para la separación de ésteres de alquilo (divisional de solicitud n° 1387-2010)
UY34719A (es) Proceso para la producción de inhibidores de crr
GEP201706626B (en) Synthesis of (s)-nifuratel
NI201200049A (es) Proceso para la preparación de compuestos de 2 - ( 1 - feniletil ) isoindolina - 1 - uno
CR20150006A (es) Metodo para preparar triazolopiridinas sustituidas
MX2012010443A (es) Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
FR2944023B1 (fr) Procede de preparation de superplastifiants.